• PACRITINIB CHEMBL2035187 Antineoplastic

    Alternate Names:

    ONX-0803
    SB-1518
    Pacritinib
    SB1518
    SB-1518|||(16E)-11-[2-(1-PYRROLIDINYL)ETHOXY]-14,19-DIOXA-5,7,27-TRIAZATETRACYCLO[19.3.1.12,6.18,12]HEPTACOSA-1(25),2,4,6(27),8,10,12(26),16,21,23-DECAENE
    11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19.3.1.1(2,6).1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENE
    (16E)-11-[2-(1-PYRROLIDINYL)ETHOXY]-14,19-DIOXA-5,7,27-TRIAZATETRACYCLO[19.3.1.12,6.18,12]HEPTACOSA-1(25),2,4,6(27),8,10,12(26),16,21,23-DECAENE
    S8057,937272-79-2
    Z-3133
    HY-16379
    SB 1518
    CS-1741
    BDBM50400312
    ABP001102
    2626AH
    AOB87797
    MOLPORT-035-395-848
    SCHEMBL1108221
    GTPL7793
    G22N65IL3O
    PACRITINIB (SB1518)
    SB1518(PACRITINIB)
    PACRITINIB(SB1518)
    PACRITINIB [INN]
    CHEMBL2181330
    UNII-G22N65IL3O
    937272-79-2
    46216796
    223366124
    7793

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antineoplastic agent
    (1 More Sources)